---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-038787"
form_type: "8-K"
ticker: "AZTA"
cik: "0000933974"
company_name: "Azenta, Inc."
filed_at: "2025-12-29T23:59:59+00:00"
generated_at: "2026-05-16T12:12:58.995642+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Azenta sells B Medical Systems to related-party Thelema for $63M; close by Mar 31, 2026

## Summary
- Sale of B Medical Systems subsidiary to Thelema S.À R.L. for USD 63M; Thelema is majority-owned by Azenta VP & B Medical CEO Luc Provost.
- Thelema deposited $9M; remaining $54M due on or before Mar 31, 2026, subject to securing final residual financing.
- If financing condition not satisfied by Mar 31, 2026, Azenta retains $5M break-up fee and may terminate.
- Proceeds to be deployed to strengthen company and drive long-term shareholder value, per CEO John Marotta.

## SEC filing metadata
- accession: 0001437749-25-038787
- form_type: 8-K
- ticker: AZTA
- cik: 0000933974
- company_name: Azenta, Inc.
- filed_at: 2025-12-29T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/933974/000143774925038787/0001437749-25-038787-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/933974/000143774925038787/azta20251226_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-038787
- JSON: https://secwatch.observer/filing/0001437749-25-038787.json
- Plain text: https://secwatch.observer/filing/0001437749-25-038787.txt

## Key facts
- Material Agreements
  Azenta, Inc. entered into Share Purchase Agreement with Thelema S.À R.L. valued at USD 63,000,000 (effective 2025-12-23).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: Thelema S.À R.L.
  - Value: USD 63,000,000
  - Effective: 2025-12-23
  source text: On December 23, 2025, Azenta Germany GmbH, a wholly owned subsidiary of Azenta, Inc. (“Azenta” or the “Company”) entered into a definitive Sale and Purchase Agreement (“Share Purchase Agreement”) with Thelema S.À R.L. (“Thelema”) relating to the entire issued share capital of B Medical Systems S.À R.L. (“B Medical”), a subsidiary of Azenta Germany GmbH.
  evidence_url: https://www.sec.gov/Archives/edgar/data/933974/000143774925038787/0001437749-25-038787-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.